Humana

AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion

Retrieved on: 
木曜日, 5月 9, 2024
Slate, Amedisys, CFO, ABA, Palliative care, Elevance Health, Speech, HCA Healthcare, Caesars Entertainment, Knowledge, Humana, ELV, Medicare, Health, Sale, Capital, HCA, BKD, LHC, History, Senior, Patient, Acquisition, Hospice, Interim, Annual general meeting, Audit, Nursing

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.

Key Points: 
  • NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.
  • “We are disappointed that Enhabit’s strategic review process has concluded without a sale of the Company.
  • In March, we nominated a slate of seven highly qualified candidates to stand for election at the 2024 Annual Meeting.
  • He also served myNEXUS as a Vice Chairman and in a strategic advisor role from 2018 to 2019.

AGL Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges agilon health, inc. Investors with Losses to Contact the Firm

Retrieved on: 
金曜日, 5月 3, 2024
Lead, LLP, News, Risk, Hope, COPY, Humana, IPO, UnitedHealth Group, District court, Court, Defendant, Medicare, Register, VIEW

RADNOR, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/new-cases/agilon-health-inc?utm_source=PR&utm_mediu...
    CANNOT VIEW THIS VIDEO?
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.

Humana Inc. to Present at B of A Securities Health Care Conference 2024

Retrieved on: 
木曜日, 5月 2, 2024
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, Diamond, Inc., Humana, Conference

Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.

Key Points: 
  • Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.
  • A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com .
  • The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system test and download any free software needed for access purposes.

Concert Announces Clinical Advisory Board, New Medical Policies

Retrieved on: 
水曜日, 5月 1, 2024
Cepheid variable, FDA, Biochemistry, Doctor of Philosophy, Cardiovascular disease, Vanderbilt University Medical Center, Associate, Palmetto, Prevalence, Concert, Global health, Congress, COVID, CRS, Food, Princeton University, Yale University, DRS, Duke University, Microbiology, Infection, Assistant, Molecular biology, Humana, Staphylococcus, Congressional Research Service, MD–PhD, Health, Library, Neuroscience, Research, Personalized medicine, Emory School, Public policy, Immunology, Medicine, Health policy, Maryland School, Government, Division, Rice University, University, Goucher College, Public health, MD, Duke, Staphylococcus aureus, Wake Forest University, Patient, Internal medicine

NASHVILLE, Tenn., May 1, 2024 /PRNewswire/ -- As part of its commitment to provide transparent, evidence-based medical policy and enable accurate reimbursement for a broader set of diagnostic services, Concert today announced the establishment of an advisory board of experts in clinical laboratory medicine and the release of policies for an expanded scope of routine and advanced laboratory testing.

Key Points: 
  • The newly formed board will advise Concert on its clinical laboratory content.
  • "Concert is working to align payers, providers, and labs to enable patient access to evidence-based testing," said Dr. Girish Putcha.
  • Following are brief bios on each member of the new clinical advisory board, in alphabetical order by last name.
  • Recent roles include Director of Laboratory Science at Palmetto's MolDX program, Chief Medical Officer and Clinical Laboratory Director of Freenome, and Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) member.

AGL Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against agilon health, inc. on Their Behalf (AGL)

Retrieved on: 
日曜日, 4月 21, 2024
Lead, LLP, News, Risk, Hope, COPY, Humana, IPO, UnitedHealth Group, District court, Court, Defendant, Medicare, Register, VIEW

RADNOR, Pa., April 21, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 21, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.

AGL CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit

Retrieved on: 
日曜日, 4月 14, 2024
Lead, LLP, News, Risk, Hope, COPY, Humana, IPO, UnitedHealth Group, District court, Court, Defendant, Medicare, Register

RADNOR, Pa., April 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

50%+ of Medicare Eligibles Selected a Medicare Advantage Plan in 2024 per Mark Farrah Associates’ Report

Retrieved on: 
月曜日, 4月 29, 2024
Insurance, Finance, Banking, Professional Services, Public Policy, Government, Healthcare Reform, General Health, Data Analytics, Pharmaceutical, Health, CVS, Humana, Cigna, PDP, MFA, UnitedHealth Group, Medicare, Health insurance

Mark Farrah Associates (MFA), www.markfarrah.com , recently assessed Medicare Advantage (MA), including Medicare Advantage with Prescription Drug Plan (MA-PD) and Prescription Drug Plan (PDP) performance, market share and market growth by state as of April 1, 2024.

Key Points: 
  • Mark Farrah Associates (MFA), www.markfarrah.com , recently assessed Medicare Advantage (MA), including Medicare Advantage with Prescription Drug Plan (MA-PD) and Prescription Drug Plan (PDP) performance, market share and market growth by state as of April 1, 2024.
  • Report findings indicate more than half of people eligible for Medicare selected a Medicare Advantage plan and another third selected a Part D - prescription drug plan in 2024.
  • Total MA membership exceeded 33.4 million and Medicare stand-alone PDPs covered nearly 22.7 million members.
  • Many companies conduct their post-OEP (Open Enrollment Period) competitive assessments by using tools such as Mark Farrah Associates’ (MFA) Medicare Business Online™, Medicare Benefits Analyzer™, and Health Coverage Portal™.

agilon health, inc. Investors: May 20, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Retrieved on: 
土曜日, 4月 27, 2024
Class Action Lawsuit, Professional Services, Legal, Lead, LLP, News, Risk, Hope, COPY, Humana, IPO, UnitedHealth Group, District court, Court, Defendant, Medicare, Register, VIEW

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

EXL announces speakers for AI in Action event

Retrieved on: 
木曜日, 4月 11, 2024
Humana, Consumer, EDT, Hope, Bias, Travel, AI, Health, Insurance, Acceleration, Scale, Jaitly, Prudential Financial, Senior, Public utility, Microsoft, Privacy, EXL, Business, Analytics, Organization, Growth, Liberty Mutual

The event will explore how businesses are making a real impact using data and AI to reinvent business models and unlock growth.

Key Points: 
  • The event will explore how businesses are making a real impact using data and AI to reinvent business models and unlock growth.
  • The full agenda for the event includes:
    Welcome and opening remarks: EXL's Vishal Chhibbar , will kick off the event with a preview of the agenda and introduce an exciting line-up of speakers from EXL as well as client and partner organizations.
  • He’ll be joined by Guy Adami , an original member of CNBC’s Fast Money, to discuss the real-world impact of AI on business.
  • Starting at 11:35 a.m. EDT, EXL will offer breakout sessions with demonstrations of generative AI solutions for specific industry use cases:
    Transforming customer experience for Retail, Travel, Utilities and more
    For more information about the event, including the registration, full agenda and list of speakers, please visit the event website here .

(AGL) CLASS ACTION ANNOUNCMENT: Kessler Topaz Meltzer & Check, LLP Notifies agilon health, inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
水曜日, 4月 10, 2024
Lead, LLP, News, Risk, Hope, COPY, Humana, IPO, UnitedHealth Group, District court, Court, Defendant, Medicare, Register

RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • One of agilon’s key financial metrics is “medical margin,” which the Company defines as medical services revenue less medical services expenses.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.